MediLumine’s Fenestra® imaging agents for preclinical computed tomography will be presented at the upcoming WMIC.
Fenestra® LC and Fenestra® VC imaging agents are used for a wide array of applications in preclinical computed tomography and molecular imaging. These hepatocyte selective nanoemulsions help to enable co-registration of soft tissue CT data for multimodal molecular imaging, quantification of metastatic tumor burdens, 4D imaging for characterization of murine cardiovascular disease and quantitative assessments of anti-angiogenic therapies.
A recent study offers insights into a novel approach to cardiac repair by inhibiting ENPP1, an enzyme critical to regulating extracellular nucleotide metabolism. MediLumine’s Fenestra
Recent advancements in high-resolution micro CT imaging have opened new doors for researchers, enabling them to explore microvascular structures in unprecedented detail. Unlocking the Power
Copyright © 2024 · MediLumine, Inc · All Rights Reserved
